Skip to main content

Medicine Matters branded image Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in oncology

IN FOCUS | ESMO Congress 2021

18-09-2021 | ESMO 2021 | Conference coverage | Video

Promising early results for cetrelimab plus erdafitinib reported for advanced UC

Thomas Powles explains why the interim results of the NORSE trial of first-line cetrelimab plus erdafitinib in FGFR-altered advanced urothelial cancer not only justify its continuance, but also point to the need for larger studies of the combination in this setting.

This independent video interview was supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

ESMO Congress 2021

Access our ongoing coverage including the latest news and expert video interviews.

IN FOCUS | Lung & thoracic cancers

09-09-2021 | WCLC 2021 | Conference coverage | News

Durvalumab–tremelimumab plus chemo ‘a potential new first-line option’ for metastatic NSCLC

The addition of durvalumab plus tremelimumab to chemotherapy significantly improves the outcomes of people with untreated metastatic non-small-cell lung cancer, shows the POSEIDON trial.

IN FOCUS | Genitourinary cancers

08-09-2021 | Prostate cancer | News

PRONOUCE fails to resolve CV safety questions for GnRH antagonists, agonists

Slow recruitment and low event rates have led to early termination of the PRONOUNCE trial, which hoped to determine the relative cardiovascular safety of gonadotropin-releasing hormone antagonists and agonists in men with prostate cancer.

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox

IN FOCUS | Breast cancer

09-08-2021 | Breast cancer | News

Statins linked to improved TNBC survival

Statin use in the 12 months after diagnosis of early-stage triple-negative breast cancer is associated with improved survival in older women, findings indicate.

IN FOCUS | COVID-19 & cancer

27-08-2021 | COVID-19 | News

PTSD not uncommon in cancer patients during COVID-19 pandemic

Around a fifth of people with cancer included in the French COVIPACT study reported symptoms consistent with post-traumatic stress disorder during the first national lockdown in response to the COVID-19 outbreak, find the investigators.


Interviews with clinical experts on cancer patient care

Image Credits